Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

This was the stock's second consecutive day of losses.

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, ...

Boston Scientific Corp. gained a second U.S. FDA approval for its Farapulse pulsed field ablation catheter, expanding its use into drug-refractory, symptomatic persistent atrial fibrillation (AF) in ...

Undeniably, Barchart’s screener for unusual stock options volume is an important tool for deciphering market sentiment, ...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2025, on Wednesday, July 23 ...

Boston Scientific Down Over 7%, on Pace for Largest Percent Decrease Since November 2020 — Data Talk Global News Select Apr 4, 2025, 9:41:00 AM ...

Boston Scientific Corp Boston Scientific Corp BSX Stock XNYS Rating as of Jul 4, 2025 Read Company Report Download PDF ...